Things are Looking up Since We Started Listening to Patients

Clinical and healthcare decision makers have repeatedly endorsed patient-centered care as a goal of the health system. However, traditional methods of evaluation reinforce societal views, and research focusing on views of patients is often referred to as ‘soft science.’ Conjoint analysis presents a scientifically rigorous research tool that can be used to understand patient preferences and inform decision making. This paper documents applications of conjoint analysis in medicine and systematically reviews this literature in order to identify publication trends and the range of topics to which conjoint analysis has been applied. In addition, we document important methodological aspects such as sample size, experimental design, and method of analysis.Publications were identified through a MEDLINE search using multiple search terms for identification. We classified each article into one of three categories: clinical applications (n = 122); methodological contributions (n = 56); and health system applications (n = 47). Articles that did not use or adequately discuss conjoint analysis methods (n = 164) were discarded. We identified a near exponential increase in the application of conjoint analyses over the last 10 years of the study period (1997–2007). Over this period, the proportion of applications on clinical topics increased from 40% of articles published in MEDLINE from 1998 to 2002, to 64% of articles published from 2003 to 2007 (p = 0.002).The average sample size among articles focusing on health system applications (n = 556) was significantly higher than clinical applications (n = 277) [p = 0.001], although this 2-fold difference was primarily due to a number of outliers reporting sample sizes in the thousands. The vast majority of papers claimed to use orthogonal factorial designs, although over a quarter of papers did not report their design properties. In terms of types of analysis, logistic regression was favored among clinical applications (28%), while probit was most commonly used among health systems applications (38%). However, 25% of clinical applications and 33% of health systems articles failed to report what regression methods were used. We used the International Classification of Diseases — version 9 (ICD-9) coding system to categorize clinical applications, with approximately 26% of publications focusing on neoplasm. Program planning and evaluation applications accounted for 22% of the health system articles.While interest in conjoint analysis in health is likely to continue, better guidelines for conducting and reporting conjoint analyses are needed.

[1]  R. Luce,et al.  Simultaneous conjoint measurement: A new type of fundamental measurement , 1964 .

[2]  Vithala R. Rao,et al.  Conjoint Measurement- for Quantifying Judgmental Data , 1971 .

[3]  G. C. Pascoe,et al.  Patient satisfaction in primary health care: a literature review and analysis. , 1983, Evaluation and program planning.

[4]  J. Ratcliffe THE USE OF CONJOINT ANALYSIS TO ELICIT WILLINGNESS-TO-PAY VALUES , 2000, International Journal of Technology Assessment in Health Care.

[5]  David L. Greene,et al.  Estimating daily vehicle usage distributions and the implications for limited-range vehicles , 1985 .

[6]  John F P Bridges,et al.  Patient-based health technology assessment: A vision of the future , 2007, International Journal of Technology Assessment in Health Care.

[7]  J. Louviere,et al.  Combining Revealed and Stated Preference Methods for Valuing Environmental Amenities , 1994 .

[8]  D. Hensher,et al.  Stated Choice Methods: Analysis and Applications , 2000 .

[9]  John Bates,et al.  ECONOMETRIC ISSUES IN STATED PREFERENCE ANALYSIS , 1988 .

[10]  K. Lancaster A New Approach to Consumer Theory , 1966, Journal of Political Economy.

[11]  M. Ryan,et al.  Using discrete choice experiments in health economics: moving forward , 2003 .

[12]  Emily Lancsar,et al.  Discrete choice experiments to measure consumer preferences for health and healthcare , 2002, Expert review of pharmacoeconomics & outcomes research.

[13]  A. Gustafsson,et al.  Conjoint Analysis as an Instrument of Market Research Practice , 2000 .

[14]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[15]  Philippe Cattin,et al.  Commercial Use of Conjoint Analysis: An Update , 1989 .

[16]  L. Goldman,et al.  Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease , 2005, Circulation.

[17]  N. J. A. Sloane,et al.  Tables of Orthogonal Arrays , 1999 .

[18]  R. Sheldon,et al.  STATED PREFERENCE METHODS. AN INTRODUCTION , 1988 .

[19]  K. Train Discrete Choice Methods with Simulation , 2003 .

[20]  Albert Hauber,et al.  Patient Preference Methods - A Patient Centered Evaluation Paradigm , 2007 .

[21]  Andreas Herrmann,et al.  Conjoint Measurement: Methods and Applications , 2000 .

[22]  D. Wittink,et al.  Commercial Use of Conjoint Analysis: A Survey , 1982 .

[23]  Robin Segal,et al.  Forecasting the Market for Electric Vehicles in California Using Conjoint Analysis , 1995 .

[24]  John F P Bridges,et al.  Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. , 2003, Applied health economics and health policy.

[25]  Mark Wardman,et al.  A COMPARISON OF REVEALED PREFERENCE AND STATED PREFERENCE MODELS OF TRAVEL BEHAVIOUR , 1988 .

[26]  M Ryan,et al.  Eliciting public preferences for healthcare: a systematic review of techniques. , 2001, Health technology assessment.

[27]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[28]  Matthew F. Bingham,et al.  Modeling choice behavior for new pharmaceutical products. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[29]  M Wardman,et al.  THE DESIGN OF STATED PREFERENCE TRAVEL CHOICE EXPERIMENTS. WITH SPECIAL REFERENCE TO INTERPERSONAL TASTE VARIATIONS , 1988 .

[30]  Kathryn A Phillips,et al.  Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. , 2002, Health services research.

[31]  Peter O. Barnard,et al.  THE ROLE OF STATED PREFERENCE METHODS IN STUDIES OF TRAVEL CHOICE , 1987 .

[32]  J. Bridges,et al.  Can pharmacoeconomics and outcomes research contribute to the empowerment of women affected by breast cancer? , 2008, Expert review of pharmacoeconomics & outcomes research.

[33]  A. Scott,et al.  Advances in health economics , 2002 .

[34]  J. Bridges What can economics add to health technology assessment? Please not just another cost-effectiveness analysis! , 2006, Expert review of pharmacoeconomics & outcomes research.

[35]  Mark J. Garratt,et al.  Efficient Experimental Design with Marketing Research Applications , 1994 .

[36]  M. Bradley,et al.  REALISM AND ADAPTATION IN DESIGNING HYPOTHETICAL TRAVEL CHOICE CONCEPTS , 1988 .

[37]  Jordan J. Louviere,et al.  CONJOINT ANALYSIS MODELLING OF STATED PREFERENCES , 1988 .

[38]  M Ryan,et al.  Using conjoint analysis to elicit preferences for health care , 2000, BMJ : British Medical Journal.

[39]  Mandy Ryan,et al.  Using discrete choice experiments to value health care programmes: current practice and future research reflections. , 2003, Applied health economics and health policy.

[40]  Kenneth E. Train,et al.  Discrete Choice Methods with Simulation , 2016 .

[41]  Mandy Ryan,et al.  Use of discrete choice experiments to elicit preferences , 2001 .